Publicacións

Publicacións de Sonia Eiras Penas

87 resultados

2026

  1. Addiction as a cardiometabolic disease: a neurocardiometabolic framework and the emerging role of GLP-1 receptor therapies

    European Heart Journal Open, Vol. 6, Núm. 4

  2. Combined SGLT2i and GLP1ra therapy reduces all-cause mortality in people with diabetes, with greater benefit in women

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 36, Núm. 4

  3. Corrigendum to ‘FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil’s proatherogenic phenotype which is modulated by semaglutide’(Journal of Molecular and Cellular Cardiology, (2026), 210, C, (12-27), (S0022282825001932), 10.1016/j.yjmcc.2025.10.009)

    Journal of Molecular and Cellular Cardiology

  4. Delayed late ventricular depolarization is associated with inflammation in epicardial Fat Among females: a New avenue in cardiac electrophysiology

    Frontiers in Cardiovascular Medicine, Vol. 13

  5. External validation of atrial fibrillation risk scores in heart failure under continuous device surveillance

    Heart Rhythm, Vol. 23, Núm. 4, pp. e547-e556

  6. FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide

    Journal of Molecular and Cellular Cardiology, Vol. 210, pp. 12-27

  7. GLP-1 receptor agonists in addiction and affective disorders: Implications for dual disorders

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 148

  8. Left ventricular ejection fraction determines the pattern of left atrial remodeling in patients with heart failure without atrial fibrillation

    Clinical Research in Cardiology

  9. Multiparametric assessment of atrial cardiopathy in cryptogenic stroke patients: Implications for personalized clinical management

    European stroke journal, Vol. 11, Núm. 1

2025

  1. Concomitant Diabetes and Atrial Fibrillation: Epicardial Fat and Macrophage-Related Mechanisms

    Diabetes/Metabolism Research and Reviews, Vol. 41, Núm. 5

  2. Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failure

    European Journal of Clinical Investigation, Vol. 55, Núm. 4

  3. Multiparametric assessment of atrial cardiopathy in cryptogenic stroke patients: Implications for personalized clinical management

    European Stroke Journal

  4. Plasma small extracellular vesicles: Markers and mediators of atrial scar, in patients with atrial fibrillation

    Heart Rhythm, Vol. 22, Núm. 12, pp. 3257-3267

  5. Semaglutide Modulates Proinflammatory Epicardial Adipogenesis With Paracrine Effects on hiPSC-Atrial Cardiomyocytes

    JACC: Basic to Translational Science, Vol. 10, Núm. 9

  6. Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry

    Revista Espanola de Cardiologia, Vol. 78, Núm. 3, pp. 218-228

2024

  1. Accumulation of Inflammatory Mediators in the Normal Pericardial Fluid

    International Journal of Molecular Sciences, Vol. 25, Núm. 1

  2. Carbohydrate antigen 125 on epicardial fat and its association with local inflammation and fibrosis-related markers

    Journal of Translational Medicine, Vol. 22, Núm. 1

  3. Combined Sodium-Glucose-Transporters Inhibitors and Glucagon-Like-Peptide Receptor Agonist Compared With Monotherapy Improves Long-Term Survival: A Real-World Registry

    American Journal of Medicine, Vol. 137, Núm. 8, pp. 761-769.e1

  4. Compartmentalization of the Inflammatory Response in the Pericardial Cavity in Patients Undergoing Cardiac Surgery

    International Journal of Molecular Sciences, Vol. 25, Núm. 24

  5. Endocrine activity of dysfunctional adipose tissue: Cardiovascular risk and progression markers

    International Journal of Cardiology